Abstract:Efficient drug delivery into tumor cells while bypassing many biological barriers is still a challenge for cancer therapy. By taking advantage of the palladium (Pd)-mediated in situ activation of a prodrug and the glucose oxidase (GOD)-based β-d-glucose oxidation reaction, we developed a multisynergistic cancer therapeutic platform that combined doxorubicin (DOX)-induced chemotherapy with GOD-mediated cancer-orchestrated oxidation therapy and cancer starvation therapy. In the present work, we first synthesized DOX prodrugs (pDOXs) and temporarily assembled them with β-cyclodextrins to reduce their toxic side effects. Then, a nanoreactor was constructed by synthesizing Pd0 nanoparticles in situ within the pores of mesoporous silica nanoparticles for the conversion of pDOX into the active anticancer drug. Furthermore, GOD was introduced to decrease the pH of the tumor microenvironment and induce cancer-orchestrated oxidation/starvation therapy by catalyzing β-d-glucose oxidation to form hydrogen peroxide (H2O2) and gluconic acid. Our study provides a new strategy that employs a cascade chemical reaction to achieve combined orchestrated oxidation/starvation/chemotherapy for the synergistic killing of cancer cells and the suppression of tumor growth.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c09489?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c09489</a>.FTIR spectra, NMR spectrum, ESI–MS spectrum, N2 adsorption–desorption isotherms curves, particle size and zeta potential, hemolysis experiment, TUNEL, H&E, and blood biochemistry (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c09489/suppl_file/am0c09489_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics

One-pot Synthesis of Hollow PDA@DOX Nanoparticles for Ultrasound Imaging and Chemo-Thermal Therapy in Breast Cancer

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Transforming a Toxic Drug into an Efficacious Nanomedicine Using a Lipoprodrug Strategy for the Treatment of Patient-Derived Melanoma Xenografts.

An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety

Polymeric Prodrug by Supramolecular Polymerization

Self-assembling Doxorubicin Prodrug Forming Nanoparticles for Cancer Chemotherapy: Synthesis and Anticancer Study in Vitro and in Vivo.

A novel nanoassembled doxorubicin prodrug with a high drug loading for anticancer drug delivery

Nanocomplexes of Doxorubicin and DNA Fragments for Efficient and Safe Cancer Chemotherapy.

Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy

Supramolecular Engineering of Polymeric Nanodrugs for Antitumor Chemotherapy

Prodrug-Based Nanoreactors with Tumor-Specific In Situ Activation for Multisynergistic Cancer Therapy

The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy

Nanoscale aggregation of doxorubicin-short peptide conjugates for enzyme-responsive delivery with various MOF carriers: In-silico steps towards smart cancer chemotherapy

Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy

Enzyme- and Ph-Sensitive Branched Polymer-Doxorubicin Conjugate-Based Nanoscale Drug Delivery System for Cancer Therapy

Bioinspired Nano‐Prodrug with Enhanced Tumor Targeting and Increased Therapeutic Efficiency

Enzymatic drug release cascade from polymeric prodrug nanoassemblies enables targeted chemotherapy

Anticancer Drug Nanomicelles Formed By Self-Assembling Amphiphilic Dendrimer To Combat Cancer Drug Resistance

A Preloaded Amorphous Calcium Carbonate/Doxorubicin@Silica Nanoreactor for Ph‐responsive Delivery of an Anticancer Drug